Organon & Co | OGN - Stock

Stock Price
13.40
Daily Change
0.04 0.30%
Monthly
43.62%
Yearly
48.48%
Q2 Forecast
13.13

Organon & Co reported $1.37B in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Celltrion KRW 122.94B 2.59T Dec/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Gilead Sciences USD 1.91B 140M Mar/2026
Glaxosmithkline GBP 6.12B 46M Sep/2025
Kangmei Pharma CNY 2.45B 12.27M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Merck USD 6.48B 179M Mar/2026
Novartis USD 6.42B 114M Sep/2025
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Organon & Co USD 1.37B 33M Mar/2026
Pharma Mar EUR 53.12M 2.48M Mar/2026
Qiagen NV USD 301.89M 11.66M Dec/2025
Sartorius EUR 827.1M 34.9M Mar/2026
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024